DOT Oral Fluid Drug Testing: What Changed and Where Do Things Stand Today?
Updated August 2026
There has been significant discussion throughout the drug and alcohol testing industry about the U.S. Department of Transportation's move toward oral fluid drug testing.
This has also created some understandable confusion.
Has DOT approved oral fluid testing? Yes.
Can DOT-regulated employers begin replacing urine drug tests with oral fluid testing today? Not yet.
The distinction is important for employers, Designated Employer Representatives (DERs), collectors, safety professionals, Substance Abuse Professionals (SAPs), and employees subject to DOT drug and alcohol testing requirements.
This article explains what changed, why oral fluid testing was added to the DOT program, and where implementation stands today.
DOT Authorized Oral Fluid Testing in 2023
On May 2, 2023, the U.S. Department of Transportation published a final rule amending 49 CFR Part 40 to permit oral fluid testing as an additional methodology for DOT-regulated drug testing.
The rule became effective June 1, 2023.
The change did not eliminate urine testing. Instead, DOT established oral fluid testing as another authorized specimen type that employers may eventually use within the federal drug-testing program.
DOT explained that the addition of oral fluid testing could provide employers with another tool to combat specimen cheating while providing a less intrusive collection method.
Official Resource: U.S. DOT — Part 40 Final Rule: Oral Fluid Testing
Why Can't DOT Employers Use Oral Fluid Testing Yet?
This is probably the most important point for employers and employees to understand.
Although the regulation authorizing oral fluid testing became effective in 2023, DOT established an important prerequisite before employers can actually implement it.
There must be at least two laboratories certified by the U.S. Department of Health and Human Services (HHS) for oral fluid testing—one capable of serving as the primary laboratory and another capable of testing the split specimen.
Until that requirement is satisfied, DOT-regulated employers cannot implement oral fluid drug testing under 49 CFR Part 40.
As of DOT's revised June 30, 2026 Urine Specimen Collection Procedures Guidelines, DOT continued to state that there were no HHS-certified oral fluid testing laboratories with DOT-conforming devices and that oral fluid specimens therefore could not yet be collected and tested for DOT-regulated employers.
In other words:
The regulations allow oral fluid testing, but the necessary laboratory infrastructure has not yet allowed DOT implementation.
This is an important distinction when evaluating advertisements or claims suggesting that oral fluid testing is already available as a replacement for a DOT urine drug test.
Official Resource: U.S. DOT — HHS-Certified Oral Fluid Laboratories and Approved Devices
Official Resource: U.S. DOT — Drug Testing Laboratories
DOT Made Additional Changes in 2024
DOT continued preparing for eventual implementation after publication of the original 2023 rule.
On November 5, 2024, DOT published another final rule primarily addressing oral fluid testing. It became effective December 5, 2024.
Among other changes, DOT clarified requirements concerning:
Oral fluid collector qualifications
Training and mock collections
Individuals permitted to observe an oral fluid collection
Documentation of sufficient specimen volume
Temporary qualification provisions for individuals monitoring mock oral fluid collections
DOT also clarified an important training issue: being a qualified urine collector does not automatically make someone a qualified oral fluid collector.
The collection methodologies have separate qualification requirements.
Official Resource: U.S. DOT — November 2024 Part 40 Final Rule Summary
How Will Oral Fluid Testing Work Once Implemented?
Once the required HHS-certified laboratories and approved collection devices are available, employers will have another specimen option within the DOT drug-testing program.
Under 49 CFR §40.210, urine and oral fluid are the authorized specimen types for DOT drug testing.
An employer will generally select one specimen type at the beginning of a testing event rather than collecting both simultaneously.
There are circumstances, however, where a problem with the original collection may require a second collection and a different specimen type may be used.
This makes it important for employers to eventually develop clear procedures or standing orders explaining when urine versus oral fluid should be collected.
Official Regulation: U.S. DOT — 49 CFR §40.210 — Permitted Drug-Testing Specimens
Oral Fluid Collections Are Directly Observed
One of the most significant practical differences between oral fluid and routine urine collections is observation.
DOT's oral fluid procedures require the collector to be present and maintain visual contact with the employee during the collection process.
The employee positions the collection device under the observation of the collector, and the collector ensures that the collection is completed correctly and that sufficient specimen volume is obtained.
This makes oral fluid particularly significant in situations where specimen integrity or attempted manipulation is a concern.
DOT's guidance describes an oral fluid specimen collection as a direct observation collection for purposes of Part 40.
Official Regulation: U.S. DOT — 49 CFR §40.73 — Oral Fluid Collection Procedures
Can an Instant Oral Swab Be Used for a DOT Drug Test?
No.
This is another important distinction.
Many employers are already familiar with rapid or point-of-collection oral fluid tests in non-DOT workplace drug-testing programs.
Those should not be confused with DOT oral fluid testing.
DOT does not authorize point-of-collection oral fluid drug tests, instant oral swabs, hair testing, or similar alternative methodologies as substitutes for the laboratory testing required under Part 40.
A DOT oral fluid specimen will have to be collected according to DOT procedures and tested by an appropriately HHS-certified laboratory.
Therefore, an employer should not assume that an oral swab device currently used in its non-DOT program will automatically be acceptable for DOT testing.
DOT vs. Non-DOT Oral Fluid Testing
This distinction is particularly important for employers operating both DOT and non-DOT testing programs.
An employer may already use oral fluid testing as part of a non-DOT company drug and alcohol policy, depending on applicable federal and state law, contractual requirements, testing-program requirements, and company policy.
That does not mean the same procedure can currently be used for a DOT-regulated drug test.
DOT tests must comply with 49 CFR Part 40 and applicable DOT agency regulations.
Non-DOT programs may operate under employer policies, state requirements, client or contractor requirements, consortium programs, or other industry-specific rules.
This is especially relevant within oil and gas, pipeline, construction, petrochemical, refining, transportation, and other safety-sensitive industries where employees may be subject to both DOT and non-DOT testing programs.
Employers should clearly identify which testing authority applies before ordering a test.
What About Return-to-Duty and Follow-Up Tests?
Once DOT oral fluid testing becomes operational, its impact will extend beyond pre-employment and random testing.
DOT's 2023 guidance indicates that oral fluid may be used for DOT-regulated testing reasons, including pre-employment, random, reasonable suspicion/cause, post-accident in applicable circumstances, return-to-duty, and follow-up testing, subject to applicable agency-specific requirements.
That is particularly relevant to the Substance Abuse Professional (SAP) return-to-duty process.
However, until DOT's laboratory requirements for oral fluid implementation are satisfied, employers must continue using an authorized and currently operational DOT testing methodology.
Employees completing the SAP process should follow the instructions provided by their employer, DER, collection site, and other appropriate program participants concerning their return-to-duty test.
What Should DOT-Regulated Employers Do Now?
Employers do not need to wait until implementation to begin preparing.
DOT-regulated employers, DERs, C/TPAs, collection sites, and other service agents should monitor official DOT guidance and consider how oral fluid testing may eventually fit into their drug and alcohol testing programs.
Preparation may include:
Reviewing existing DOT drug and alcohol policies
Evaluating future urine-versus-oral-fluid standing orders
Reviewing collector qualification requirements
Coordinating with laboratories and C/TPAs
Training DERs and supervisors on the differences between DOT and non-DOT testing
Ensuring oral fluid devices are approved for use with the applicable HHS-certified laboratory
Monitoring DOT and HHS announcements regarding laboratory certification
Employers should avoid implementing a DOT oral fluid program prematurely simply because oral fluid testing is now referenced in Part 40.
Where Do Things Stand in 2026?
As of August 2026, DOT has established the regulatory framework for oral fluid testing, collector requirements, collection procedures, specimen requirements, and related safeguards.
But DOT's June 2026 guidance continues to state that oral fluid specimens cannot yet be collected and tested for DOT-regulated employers because the required HHS-certified laboratory capability with DOT-conforming devices is not yet available.
DOT has indicated that oral fluid testing can begin only when there are two HHS-certified oral fluid laboratories with appropriate DOT-conforming devices.
DOT also intends to publish notice when the second laboratory is certified so the regulated community knows that oral fluid testing can be performed under Part 40.
For employers, DERs, collectors, and employees, the key message is simple:
DOT oral fluid testing is authorized, but authorization is not the same as implementation.
Until DOT's implementation requirements are satisfied, employers should continue following the currently available DOT drug-testing procedures.
Staying Current With DOT Drug and Alcohol Testing Requirements
Drug and alcohol testing regulations continue to evolve, making it important for employers and safety-sensitive employees to distinguish between proposed changes, final regulations, effective regulations, and requirements that can actually be implemented.
Jared Sloan, SAP, provides DOT and non-DOT Substance Abuse Professional/SAE services and drug-free workplace consultation for employees and employers in Texas and New Mexico, including safety-sensitive industries throughout the Permian Basin.
Services include assistance involving DOT return-to-duty requirements, FMCSA Clearinghouse cases, PHMSA and other applicable DOT programs, non-DOT workplace violations, employer drug and alcohol policies, and DISA-managed program requirements as applicable.
Official Resources
U.S. Department of Transportation — Office of Drug & Alcohol Policy & Compliance (ODAPC)DOT Office of Drug & Alcohol Policy & Compliance
DOT 2023 Oral Fluid Final Rule and SummaryDOT Part 40 Oral Fluid Final Rule
Current HHS-Certified Oral Fluid Laboratory StatusDOT HHS-Certified Oral Fluid Laboratories
DOT Oral Fluid Collector ResourcesDOT Oral Fluid Collector Information
49 CFR Part 40DOT Part 40 Regulations
Comments